Shenzhen Salubris Pharmaceuticals
Pharmaceutical company with commercial and clinical programs in cardiovascular, metabolic and oncology indications.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 2 · Recruiting · Anemia
Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese ParticipantsPhase 4 · Recruiting · Healthy Participants
SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese PopulationPhase 1 · Recruiting · Uncontrolled Hypertension
A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing RegimensPhase 2 · Recruiting · Postmenopausal Women With Osteoporosis
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled HypertensionPhase 2 · Recruiting · Uncontrolled Hypertension
Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy ParticipantsPhase 1 · Not Yet Recruiting · Bioequivalence
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/shenzhen-salubris-pharmaceuticals/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.